Berinert

STN:  BL 125287
Proper Name: C1 Esterase Inhibitor (Human)
Tradename: Berinert
Manufacturer: CSL Behring GmbH, License #1765

Indication

• Treatment of acute abdominal or facial or laryngeal attacks of hereditary angioedema (HAE) in adult and adolescent patients.

Product Information

• Package Insert - Berinert

Supporting Documents

• September 15, 2021 Approval Letter - BERINERT
• Approval History, Letters, Reviews and Related Documents - Berinert
• Supporting Documents older than three years - Berinert

Related Information

• C1 Esterase Inhibitor
• CBER-Regulated Products with Supporting Documents